Value of 18F-FDG PET/CT in discrimination between indolent and aggressive non-Hodgkin's lymphoma: A study of 328 patients

被引:6
作者
Alobthani, Galal [1 ]
Romanov, Victor [1 ]
Isohashi, Kayako [1 ]
Matsunaga, Keiko [1 ]
Watabe, Tadashi [1 ]
Kato, Hiroki [1 ]
Tatsumi, Mitsuaki [2 ]
Shimosegawa, Eku [1 ]
Hatazawa, Jun [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, 2-2 Yamadaoka, Suita, Osaka, Japan
[2] Osaka Univ Hosp, Dept Radiol, 2-2 Yamadaoka, Suita, Osaka, Japan
来源
HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2018年 / 21卷 / 01期
关键词
F-18-FDG PET/CT; Time of flight (TOF); SUVmax cut-off; Detection rate; Aggressive and indolent non Hodgkin's lymphoma; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; TIME-OF-FLIGHT; HEALTH-ORGANIZATION CLASSIFICATION; FDG-PET; HISTOLOGIC SUBTYPES; COMPUTED-TOMOGRAPHY; LESION DETECTION; T-CELL; SUV;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Non-Hodgkin's lymphoma (NHL) cases with inconclusive biopsy findings are not infrequently 18 referred for fluorine-18-uorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). We searched for maximum standardized uptake value (SUVmax) cut-off values that could discriminate between indolent and aggressive NHL in conventional non-time of flight (non-TOF) F-18-FDG PET/CT and TOF F-18-FDG PET/CT. Subjects and Methods: Retrospectively, 328 patients were selected by the following inclusion criteria: biopsy-proven NHL with no more than one histopathological type; new cases with 18 less than 90 days between obtaining biopsy and F-18-FDG PET/CT scanning; recurrent cases with time interval more than six months since the last therapy with no history of transformation; and blood glucose less than 150 mg/dL. Two hundred forty six (246) selected patients were scanned with non-TOF PET/CT, and 82 18 18 patients were scanned with TOF F-18-FDG PET/CT. Results: The SUVmax of NHL tends to be higher in TOF F-18-FDG PET/CT than non-TOF F-18-FDG PET/CT. New aggressive NHL had significantly higher SUVmax than new 18 18 indolent NHL in both, non-TOF F-18-FDG PET/CT (13.6 +/- 7.7g/mL vs. 5.3 +/- 3.4g/mL, P<0.0001) and TOF F-18-FDG PET/CT (20.5 +/- 9.8g/mL vs. 6.6 +/- 4.7g/mL, P<0.0001). A receiver operating characteristic curve analysis for 18 new cases in non-TOF F-18-FDG PET/CT (n=204), demonstrated SUVmax of 10g/mL as the most balanced cutoff between aggressive and indolent NHL, with the area under the curve (AUC) of 86%, specificity of 94%, 18 and sensitivity of 71%. While SUVmax of 13g/mL was the most balanced cut-off for new cases in TOF F-18-FDG PET/CT (n=57), with AUC of 91%, specificity of 95.5%, and sensitivity of 77%. Conclusion: Both SUVmax>10g/mL in non-TOF F-18-FDG PET/CT and > 13g/mL in TOF F-18-FDG PET/CT were highly suggestive of an aggressive nature of NHL, while there was an overlap between indolent and aggressive NHL in the lower SUV max levels.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 46 条
  • [1] A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
    Adams, Michael C.
    Turkington, Timothy G.
    Wilson, Joshua M.
    Wong, Terence Z.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (02) : 310 - 320
  • [2] Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET
    Akamatsu, Go
    Mitsumoto, Katsuhiko
    Taniguchi, Takafumi
    Tsutsui, Yuji
    Baba, Shingo
    Sasaki, Masayuki
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (01) : 226 - 230
  • [3] [Anonymous], J NATL COMPR CANC S1
  • [4] [Anonymous], 2009, SEER CANC STAT REV
  • [5] [Anonymous], 2015, BIOMED RES INT
  • [6] New approach to classifying non-hodgkin's lymphomas: Clinical features of the major histologic subtypes
    Armitage, JO
    Weisenburger, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2780 - 2795
  • [7] Variation of SUV in Time of Flight and Non-Time of Flight Dual Time Oncologic PET-CT
    Campbell, J.
    Hung, B.
    Wong, C.
    Johnson, M.
    Wong, R.
    Roumayah, Y.
    Wong, C.
    [J]. MEDICAL PHYSICS, 2011, 38 (06)
  • [8] Chavdarova LI, 2013, HELL J NUCL MED, V16, P223, DOI 10.1967/s002449910098
  • [9] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
    Cheson, Bruce D.
    Fisher, Richard I.
    Barrington, Sally F.
    Cavalli, Franco
    Schwartz, Lawrence H.
    Zucca, Emanuele
    Lister, T. Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3059 - +
  • [10] Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Conte, Michael J.
    Bowen, Deborah A.
    Wiseman, Gregory A.
    Rabe, Kari G.
    Slager, Susan L.
    Schwager, Susan M.
    Call, Timothy G.
    Viswanath, David S.
    Zent, Clive S.
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2079 - 2084